A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2474-0
Published Online: 2014-05-13
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McRee, Autumn J.
Davies, Janine M.
Sanoff, Hanna G.
Goldberg, Richard M.
Bernard, Stephen
Claire Dees, E.
Keller, Kimberly
Ivanova, Anastasia
O’Neil, Bert H.
Text and Data Mining valid from 2014-05-13